|
|
Elucidating the Mechanisms of Translational Approaches to Enhance Recovery of Aged Muscle |
| 1 F99 AG073493-01 |
|
NIA |
2021 |
|
|
Motor Profiles as Novel Biomarker for Alzheimer’s Disease |
| 1 K01 AG073578-01 |
|
NIA |
2021 |
|
|
A Meal Delivery and Exercise Intervention to Increase Resilience in Homebound Older Adults |
| 1 K23 AG072042-01 |
|
NIA |
2021 |
|
|
Examining the role of the neighborhood environment on muscle function in older adults |
| 1 K99 AG066846-01A1 |
|
NIA |
2021 |
|
|
Compensation Training and Lifestyle Modifications to promote healthy aging in persons at risk for Alzheimer's disease: a digital application supported intervention |
| 1 R01 AG066748-01A1 |
|
NIA |
2021 |
|
|
COCOA flavanols to improve walking performance in PAD: the COCOA-PAD II Trial |
| 1 R01 AG068458-01A1 |
|
NIA |
2021 |
|
|
Integrating Risk Trajectories and Social Determinants to Enhance Cardiovascular Risk Assessment in Older Adults |
| 1 R01 AG069938-01A1 |
|
NIA |
2021 |
|
|
The role of IGF-1 signaling in vascular smooth muscle cells in age-related vascular cognitive impairment and dementia |
| 1 R01 AG070915-01A1 |
|
NIA |
2021 |
|
|
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Safety and Efficacy of CT1812 in Subjects with Dementia with Lewy Bodies |
| 1 R01 AG071643-01 |
|
NIA |
2021 |
|
|
Functional Impairment in Middle-Aged Adults |
| 1 R01 AG071730-01A1 |
|
NIA |
2021 |
